Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

4.2%

5 terminated/withdrawn out of 119 trials

Success Rate

90.6%

+4.1% vs industry average

Late-Stage Pipeline

22%

26 trials in Phase 3/4

Results Transparency

4%

2 of 48 completed trials have results

Key Signals

5 recruiting2 with results

Enrollment Performance

Analytics

N/A
49(45.4%)
Phase 2
26(24.1%)
Phase 3
17(15.7%)
Phase 4
9(8.3%)
Phase 1
7(6.5%)
108Total
N/A(49)
Phase 2(26)
Phase 3(17)
Phase 4(9)
+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (119)

Showing 20 of 119 trials
NCT07434661Phase 3Not Yet Recruiting

Apixaban VS Warfarin in AF Pts First Three Months After Repair or BIO AVR MVR

Role: lead

NCT07372196Not ApplicableRecruiting

Left Bundle Branch Pacing in Patients With Hypertrophic Cardiomyopathy After Myectomy

Role: lead

NCT06443931Not ApplicableCompleted

Cryoablation of Intercostal Nerves for Pain Management in Early Postoperative Period in Patients With Minimally Invasive Mitral Valve Surgery

Role: lead

NCT03772990Phase 4Completed

Calcium Administration in Cardiac Surgery

Role: lead

NCT03729011Phase 4Completed

Delirium Reduction by Volatile Anesthesia in Cardiac Surgery

Role: lead

NCT05911100Active Not Recruiting

State of Oxygen Metabolism, Cardiovascular and Respiratory System Reserve Capacity in Patients Who Underwent COVID-19

Role: lead

NCT06069115Recruiting

Radiotherapy Exposed Lung Injury: Effect on Functioning - Cohort

Role: lead

NCT02209350Phase 1Completed

Study of the AFB and Stenting of the Iliac Arteries

Role: lead

NCT05757947Not ApplicableRecruiting

Study of the No-touch Saphenous Vein Graft

Role: lead

NCT04506814Not ApplicableWithdrawn

Endocardial Vs Epicardial Ablation for Recurrent Paroxysmal AF

Role: collaborator

NCT05856461Not ApplicableUnknown

Pulmonary Artery Denervation in Patients With Atrial Fibrillation and Group 2 of Pulmonary Hypertension

Role: lead

NCT05643664Not ApplicableUnknown

The Role of Artificial Intelligence in the Treatment of Abdominal Aortic Aneurysms

Role: lead

NCT05634018Unknown

Comparison of the Biomechanical Properties of the Wall of an Aneurysmal-altered Abdominal Aorta According to the Results of in Vivo Ultrasound and an Associated Study of Strength Characteristics in Vitro

Role: lead

NCT05322798Not ApplicableCompleted

High-frequency SCS in Treatment of Chronic Limb-Threatening Ischemia

Role: lead

NCT05257161Not ApplicableRecruiting

Carotid Revascularization With MicroNet Covered Stent Comparing Early Neurological Outcomes With Distal Versus Proximal EPS

Role: lead

NCT05222061Not ApplicableUnknown

A Study of Drug Coated Balloon For Treating the Side Branch in Complex Bifurcation Lesions

Role: lead

NCT02580084Not ApplicableCompleted

Clinical Study of the Aorta-femoral Bypass and Hybrid Intervention and the Iliac Arteries With Stenting and Plasty of the Common Femoral Artery Effectiveness in Patients With the Iliac Segment and Femoral Artery Occlusive Disease (TASC C, D)

Role: lead

NCT05073094Phase 4Unknown

Esmolol for Myocardial Protection in Hypertrophic Obstructive Cardiomyopathy

Role: lead

NCT03488199Not ApplicableCompleted

The SIBERIA Trial (Acculink™ Versus CGuard™)

Role: lead

NCT02757443Phase 3Completed

Myocardial Protection With Phosphocreatine in High-RIsk Cardiac SurgEry Patients

Role: lead